Aldeyra Therapeutics to Present at 2019 Cantor Global Healthcare Conference
September 25 2019 - 8:00AM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases, today announced that Todd C. Brady, M.D.,
Ph.D., President and CEO of Aldeyra, will present at the 2019
Cantor Global Healthcare Conference. The presentation is scheduled
to begin at 11:15 a.m. ET on Friday, October 4, 2019.
A live webcast of the presentation can be accessed on the
“Investors & Media” section of the Aldeyra website,
www.aldeyra.com. An audio replay will be available following the
live presentation and will be archived on the website for 90
days.
About Aldeyra Therapeutics Aldeyra Therapeutics is a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases. Aldeyra's lead investigational drug
product candidates are first-in-class potential treatments in
development for dry eye disease, allergic conjunctivitis,
proliferative vitreoretinopathy, and Sj�gren-Larsson Syndrome. The
company is also developing other product candidates for retinal and
systemic inflammatory diseases.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190925005482/en/
Corporate Contact: David McMullin Aldeyra Therapeutics,
Inc. Tel: 781-761-4904 ext. 218 dmcmullin@aldeyra.com Investor
& Media Contact: Scott Solomon Sharon Merrill Associates,
Inc. Tel: 617-542-5300 ALDX@investorrelations.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2023 to Apr 2024